Skip to content Skip to main menu

News & Media

Our Microbiome Determines balanced health

MOU between MD Healthcare and JBF Biopharmaceutical Research Center

관리자 2020-08-04 09:48:42 Hit 807


 

*MOU between MD Healthcare and JBF Biopharmaceutical Research Center

MD Healthcare and the Jeonnam Bioindustry Foundation (JBF) Biopharmaceutical Research Center entered an MOU for the co-development of microbiome extracellular vesicle therapeutic research and production. This agreement will accelerate development of microbiome EVs as novel therapeutics for COVID-19 and other inflammatory diseases.

2020.07.09

(http://www.mdtoday.co.kr/mdtoday/index.html?no=392646)